Lopinavir to atazanavir or darunavir switch in HIV-1-infected patients with dyslipidemia: an observational study

Yazar: Le Moal, G, Beraud, G, Prazuck, T, Hocqueloux, L, Dupuis, A, Venisse, N
Baskı/Yayın Bilgisi 2010

Impact de la prévalence du COVID-19 des personnels d’établissements médicosociaux sur le risque d’infection des résidents : étude prospective dans 17 EHPAD et MAS

Yazar: Sève, A., Rzepecki, V., Dupriez, F., Courtellemnt, L., Parienti, J., Hocqueloux, L., Prazuck, T.
Yayımlandı Med Mal Infect (2020)

S03-04 OA. Transitional and central memory CD4 T cells are highly infected in long term non progressors and elite controllers

Yazar: Descours, B, Avettand-Fenoël, V, Blanc, C, Samri, A, Mélard, A, Prazuck, T, Hocqueloux, L, Carcelain, G, Rouzioux, C, Autran, B
Baskı/Yayın Bilgisi 2009

48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial

Yazar: Yazdanpanah, Y, Khuong-Josses, M-A, Hocqueloux, L, Pialoux, G, Durant, J, Wynne, B, Granier, C, Tebas, P, Pappa, K, Min, S
Yayımlandı BMC Infect Dis (2014)

High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS‐CoV‐2 infection

Yazar: Courtellemont, L., Guinard, J., Guillaume, C., Giaché, S., Rzepecki, V., Seve, A., Gubavu, C., Baud, K., Le Helloco, C., Cassuto, G. N., Pialoux, G., Hocqueloux, L., Prazuck, T.
Yayımlandı J Med Virol (2021)

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

Yazar: Lions, C., Cabras, O., Cotte, L., Huleux, T., Gagneux-Brugnon, A., Makinson, A., Cabié, A., Bonnet, B., Duvivier, C., Hocqueloux, L., Cua, E., Cheret, A., Hustache-Mathieu, L., Obry-Roguet, V., Jacomet, C., Poizot-Martin, I.
Yayımlandı BMC Infect Dis (2019)

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

Yazar: Lévy, Y., Lacabaratz, C., Lhomme, E., Wiedemann, A., Bauduin, C., Fenwick, C., Foucat, E., Surenaud, M., Guillaumat, L., Boilet, V., Rieux, V., Bouchaud, O., Girard, P.-M., Molina, J.-M., Morlat, P., Hocqueloux, L., Richert, L., Pantaleo, G., Lelièvre, J. D., Thiébaut,, R.
Yayımlandı J Virol (2021)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Yazar: Castagna, Antonella, Maggiolo, Franco, Penco, Giovanni, Wright, David, Mills, Anthony, Grossberg, Robert, Molina, Jean-Michel, Chas, Julie, Durant, Jacques, Moreno, Santiago, Doroana, Manuela, Ait-Khaled, Mounir, Huang, Jenny, Min, Sherene, Song, Ivy, Vavro, Cindy, Nichols, Garrett, Yeo, Jane M., Aberg, J., Akil, B., Arribas, J. R., Baril, J.-G., Blanco Arévalo, J. L., Blanco Quintana, F., Blick, G., Boix Martínez, V., Bouchaud, O., Branco, T., Bredeek, U. F., Castro Iglesias, M., Clumeck, N., Conway, B., DeJesus, E., Delassus, J.-L., De Truchis, P., Di Perri, G., Di Pietro, M., Duggan, J., Duvivier, C., Elion, R., Eron, J., Fish, D., Gathe, J., Haubrich, R., Henderson, H., Hicks, C., Hocqueloux, L., Hodder, S., Hsiao, C.-B., Katlama, C., Kozal, M., Kumar, P., Lalla-Reddy, S., Lazzarin, A., Leoncini, F., Llibre, J. M., Mansinho, K., Morlat, P., Mounzer, K., Murphy, M., Newman, C., Nguyen, T., Nseir, B., Philibert, P., Pialoux, G., Poizot-Martin, I., Ramgopal, M., Richmond, G., Salmon Ceron, D., Sax, P., Scarsella, A., Sension, M., Shalit, P., Sighinolfi, L., Sloan, L., Small, C., Stein, D., Tashima, K., Tebas, P., Torti, C., Tribble, M., Troisvallets, D., Tsoukas, C., Viciana Fernández, P., Ward, D., Wheeler, D., Wilkin, T., Yeni, G.-P., Louise Martin-Carpenter, J., Uhlenbrauck, Gina
Baskı/Yayın Bilgisi 2014